FI41741B - - Google Patents

Info

Publication number
FI41741B
FI41741B FI0988/63A FI98863A FI41741B FI 41741 B FI41741 B FI 41741B FI 0988/63 A FI0988/63 A FI 0988/63A FI 98863 A FI98863 A FI 98863A FI 41741 B FI41741 B FI 41741B
Authority
FI
Finland
Application number
FI0988/63A
Inventor
D Hartley
G Hughes
H Smith
Original Assignee
H Smith
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H Smith filed Critical H Smith
Application granted granted Critical
Publication of FI41741B publication Critical patent/FI41741B/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Transmission Devices (AREA)
FI0988/63A 1962-05-15 1963-05-13 FI41741B (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19497262A 1962-05-15 1962-05-15

Publications (1)

Publication Number Publication Date
FI41741B true FI41741B (fi) 1969-10-31

Family

ID=22719572

Family Applications (1)

Application Number Title Priority Date Filing Date
FI0988/63A FI41741B (fi) 1962-05-15 1963-05-13

Country Status (13)

Country Link
US (1) US3502699A (fi)
JP (1) JPS4812737B1 (fi)
AT (2) AT272532B (fi)
BR (1) BR6349095D0 (fi)
CH (1) CH494213A (fi)
DE (3) DE1468642B1 (fi)
DK (2) DK114340B (fi)
ES (2) ES288359A1 (fi)
FI (1) FI41741B (fi)
FR (1) FR3896M (fi)
IT (1) IT1061776B (fi)
NO (2) NO124598B (fi)
SE (5) SE323669B (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3723533A (en) * 1968-02-27 1973-03-27 American Cyanamid Co Substituted naphthalenone and naphthalenedione compounds
JPS5320840Y2 (fi) * 1973-11-21 1978-06-01
DE2718872A1 (de) * 1976-06-14 1977-12-22 Jenapharm Veb Verfahren zur herstellung von neuen gona-4,9(10)-dienen
FR2618783B1 (fr) * 1987-07-30 1991-02-01 Roussel Uclaf Nouveaux 17-aryle steroides, leurs procedes et des intermediaires de preparation comme medicaments et les compositions pharmaceutiques les renfermant
WO2015057894A1 (en) * 2013-10-15 2015-04-23 Massachusetts Institute Of Technology Methods for treating polycystic kidney disease and polycystic liver disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3069421A (en) * 1961-04-12 1962-12-18 Roussel Uclaf Process for the preparation of delta5(10)-estrene-17beta-ol-3-one and intermediates

Also Published As

Publication number Publication date
SE330164B (fi) 1970-11-09
SE330166B (fi) 1970-11-09
DE1793633C3 (de) 1973-10-04
ES288360A1 (es) 1963-12-01
AT283609B (de) 1970-08-10
FR3896M (fi) 1966-02-07
SE323668B (fi) 1970-05-11
DE1618973A1 (de) 1971-12-30
DK114340B (da) 1969-06-23
NO124597B (fi) 1972-05-08
DE1793633B2 (de) 1973-03-08
JPS4812737B1 (fi) 1973-04-23
SE323669B (fi) 1970-05-11
SE330165B (fi) 1970-11-09
NO124598B (fi) 1972-05-08
CH494213A (de) 1970-07-31
IT1061776B (it) 1983-04-30
DE1618973C3 (de) 1974-06-06
BR6349095D0 (pt) 1973-08-02
DK116056B (da) 1969-12-08
ES288359A1 (es) 1963-12-01
DE1468642B1 (de) 1971-03-11
US3502699A (en) 1970-03-24
AT272532B (de) 1969-07-10
DE1618973B2 (de) 1973-10-31
DE1793633A1 (de) 1971-12-30

Similar Documents

Publication Publication Date Title
FI41741B (fi)
BE613529A (fi)
BE614159A (fi)
BE612464A (fi)
BE612311A (fi)
BE612190A (fi)
BE609543A (fi)
BE608197A (fi)
BE604335A (fi)
BE615962A (fi)
BE592434A (fi)
BE586180A (fi)
BE566353A (fi)
BE559145A (fi)
BE541929A (fi)
BE538831A (fi)
BE538252A (fi)
BE489310A (fi)
BE616166A (fi)
BE380301A (fi)
AU480751A (fi)
AU269855A (fi)
BE612926A (fi)
BE613108A (fi)
BE613190A (fi)